Cell 140 , 4961 (2010)
For acute injuries, some patients notice reduced pain and improved mobility within 2-4 weeks
Obviously this ignores all those who require life long treatment due to other causes of B12 deficiency (of which there are many), thereby potentially causing great harm to the vast majority of their B12 deficient patients
Frequently Asked Questions Research References Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (Hsieh et al., J Mol Med, 2017) BPC 157 promotes tendon healing via tendon outgrowth, cell survival and cell migration, FAK and paxillin phosphorylation (Chang et al., J Appl Physiol, 2011) Regeneration or Risk
A change in urine color occasionally happens if the shot you've received contains more B12 than what your body can utilize and store at that time
(2) BPC 157 promotes the vessel relaxation mainly acting on vascular endothelial cells but much less on vascular smooth muscle cells